Should a QP audit CROs and Investigators?
Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Register now for ECA's GMP Newsletter
As third set in row of Q&A documents, the European QP Association has published a Q&A document on IMP-related questions.
The new set of questions (on the European QP Association website) is dealing with topics like:
- Completeness of the IMPD
- Reanalysis of IMPs
- Audits
- Contracts
Related GMP News
17.07.2025ICH E20 Draft Guideline on Adaptive Design for Clinical Trials
17.07.2025Update on ICH Guidelines E21 & E22
10.07.2025EMA Policy on the Publication of Clinical Data
17.06.2025EMA Implementation of ICH E6, M11 & M12
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials